Gene · 5205
Papers1,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptomic Analysis of Subtype-Specific Tyrosine Kinases as Triple Negative Breast Cancer Biomarkers. | Cancers (Basel) | 2023 | 36672350 | PubTator, text mining | PubMed |
| Bioinformatics reveal elevated levels of Myosin Vb in uterine corpus endometrial carcinoma patients which correlates to increased cell metabolism and poor prognosis. | PLoS One | 2023 | 36662766 | PubTator, text mining | PubMed |
| Interactome of Paraoxonase PON2 Reveals New Pathways for Tumor Growth Regulation. | Dokl Biochem Biophys | 2023 | 36653584 | PubTator, text mining | PubMed |
| The role of altered lipid composition and distribution in liver fibrosis revealed by multimodal nonlinear optical microscopy. | Sci Adv | 2023 | 36638165 | PubTator, text mining | PubMed |
| Dental management of a pediatric patient with progressive familial intrahepatic cholestasis having dental anomalies: a case report and brief review of the literature. | BMC Oral Health | 2023 | 36624442 | PubTator, text mining | PubMed |
| Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer. | J Endocrinol | 2023 | 36622663 | PubTator, text mining | PubMed |
| Convergent Approaches to Delineate the Metabolic Regulation of Tumor Invasion by Hyaluronic Acid Biosynthesis. | Adv Healthc Mater | 2023 | 36479976 | PubTator, text mining | PubMed |
| Design and characterization of a heterobifunctional degrader of KEAP1. | Redox Biol | 2023 | 36473314 | PubTator, text mining | PubMed |
| Evaluation of Quantification and Normalization Strategies for Phosphoprotein Phosphatase Affinity Proteomics: Application to Breast Cancer Signaling. | J Proteome Res | 2023 | 36448918 | PubTator, text mining | PubMed |
| MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer. | Mol Cancer Res | 2023 | 36445328 | PubTator, text mining | PubMed |
| Non-alcoholic fatty liver disease: the pathologist's perspective. | Clin Mol Hepatol | 2023 | 36384146 | PubTator, text mining | PubMed |
| Complete deletion of Ectromelia virus p28 impairs virus genome replication in a mouse strain, cell type, and multiplicity of infection-dependent manner. | Virus Res | 2023 | 36244618 | PubTator, text mining | PubMed |
| BACH1 promotes clear cell renal cell carcinoma progression by upregulating oxidative stress-related tumorigenicity. | Cancer Sci | 2023 | 36178067 | PubTator, text mining | PubMed |
| Survival Mixture Density Networks. | Proc Mach Learn Res | 2022 | 37706207 | PubTator, text mining | PubMed |
| Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer. | Oncol Res | 2022 | 37304008 | PubTator, text mining | PubMed |
| Real-life Progression of the Use of a Genetic Panel in to Diagnose Neonatal Cholestasis. | JPGN Rep | 2022 | 37168916 | PubTator, text mining | PubMed |
| Contrast subgraphs allow comparing homogeneous and heterogeneous networks derived from omics data. | Gigascience | 2022 | 36852877 | PubTator, text mining | PubMed |
| An integrated analysis of the cancer genome atlas data discovers a hierarchical association structure across thirty three cancer types. | PLOS Digit Health | 2022 | 36812605 | PubTator, text mining | PubMed |
| Causal Discovery in High-dimensional, Multicollinear Datasets. | Front Epidemiol | 2022 | 36778756 | PubTator, text mining | PubMed |
| Compound Heterozygous MYO5B Mutation, a Cause of Infantile Cholestasis: A Case Report. | JNMA J Nepal Med Assoc | 2022 | 36705120 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5205/papers?page=15